PARIS–( SERVICE CORD)– Owkin, the very first end-to-end AI-biotech that utilizes sophisticated causal AI to unlock accuracy medication exploration, growth and diagnostics, delights in to introduce a brand-new collaboration with AstraZeneca, an international biopharmaceutical firm, to create an AI-powered device to pre-screen for gBRCA anomalies (gBRCAm) in bust cancer cells straight from digitized pathology slides. As component of Owkin’s continuous cooperation with Gustave Roussy and The Centre Léon Bérard with Picture, a Fre
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/owkin-announces-partnership-with-astrazeneca-to-develop-an-ai-gbrca-pre-screen-solution-for-breast-cancer/
